News

More information: Diagnostic overshadowing in systemic lupus erythematosus (SLE): A qualitative study, Lupus (2025). DOI: 10.1177/09612033251345184 ...
In this month’s episode, we speak with Dr. Jane Salmon about Antiphospholipid Syndrome, or APS. Dr. Salmon is a Collette Kean Research Professor and the director of the Lupus and APS Center of ...
MECHANICSVILLE, Va. — For Terrina Williams, drawing is more than just a hobby — it's a path to healing. Each intricate mark made on paper helps her cope with the chronic pain caused by lupus ...
There aren’t any medicines that treat lupus fog specifically. But many people find that their lupus fog is worse during flares — so treatments that help to prevent or treat lupus flares may also help ...
AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK drugmaker plows billions into the growing area of cell therapy called ...
Dapirolizumab pegol, a novel CD40L inhibitor, is superior to placebo for achieving low disease activity and remission in systemic lupus erythematosus, according to data presented at the EULAR 2025 ...
Systemic lupus erythematosus articles from across Nature Portfolio Systemic lupus erythematosus is a potentially fatal autoimmune disease that is characterized by wide-spread inflammation and ...
The primary endpoint, which was measured by the British Isles Lupus Assessment Group-based Composite Lupus Assessment/BICLA at Week 48, showed positive results. It’s important to note that the ...
Gazyva has also been filed for the lupus nephritis indication in Europe, said Roche, which is also expecting a readout from the phase 3 ALLEGORY trial in a broader SLE population later in 2025 and ...
UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.
What Is a Venn Diagram? A Venn diagram is a graphic that identifies the traits that two or more sets of things, concepts, or people share and don't share. Circles representing each trait overlap ...
Azathioprine is used across the entire range of lupus manifestations. It is usually dosed at 100–150 mg daily (or 1.5–2 mg/kg) initially whereas maintenance with lower doses is also possible.